Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1956 1
1958 1
1964 1
1967 4
1968 8
1969 8
1970 11
1971 14
1972 22
1973 26
1974 37
1975 53
1976 88
1977 80
1978 101
1979 139
1980 162
1981 146
1982 189
1983 203
1984 239
1985 284
1986 248
1987 323
1988 292
1989 391
1990 443
1991 530
1992 539
1993 676
1994 772
1995 1051
1996 1179
1997 1318
1998 1407
1999 1473
2000 1574
2001 1588
2002 1621
2003 1754
2004 1906
2005 2138
2006 2404
2007 2428
2008 2613
2009 2950
2010 3231
2011 3536
2012 4109
2013 4503
2014 5320
2015 5525
2016 5699
2017 6138
2018 6343
2019 6675
2020 7249
2021 8326
2022 8527
2023 8643
2024 4549

Text availability

Article attribute

Article type

Publication date

Search Results

110,041 results

Results by year

Filters applied: . Clear all
Page 1
Cost-effectiveness analysis of myopia management: A systematic review.
Agyekum S, Chan PP, Zhang Y, Huo Z, Yip BHK, Ip P, Tham CC, Chen LJ, Zhang XJ, Pang CP, Yam JC. Agyekum S, et al. Front Public Health. 2023 Feb 27;11:1093836. doi: 10.3389/fpubh.2023.1093836. eCollection 2023. Front Public Health. 2023. PMID: 36923029 Free PMC article. Review.
The primary outcomes of this systematic review were costs, quality-adjusted life years (QALYs), and incremental cost-effectiveness ratio (ICER). The secondary outcomes included utility values and net monetary benefits (NMB). One study determined the cost-e
The primary outcomes of this systematic review were costs, quality-adjusted life years (QALYs), and incremental cost-effectiveness
Understanding cost effectiveness in neurology.
Sánchez Fernández I. Sánchez Fernández I. J Neurol Sci. 2023 Dec 15;455:122787. doi: 10.1016/j.jns.2023.122787. Epub 2023 Nov 13. J Neurol Sci. 2023. PMID: 37979414 Review.
This manuscript aims to introduce the rationale, terminology, advantages, and limitations of cost-effectiveness analysis. Cost-effectiveness analysis compares health interventions and evaluates their incremental value and their incrementa …
This manuscript aims to introduce the rationale, terminology, advantages, and limitations of cost-effectiveness analysis
Costs, cost-effectiveness, and context.
Engle-Stone R, Adams KP. Engle-Stone R, et al. Am J Clin Nutr. 2022 Nov;116(5):1193-1194. doi: 10.1093/ajcn/nqac254. Epub 2023 Feb 10. Am J Clin Nutr. 2022. PMID: 36191291 Free PMC article. No abstract available.
Cost-Effectiveness Analysis of Myopia Progression Interventions in Children.
Agyekum S, Chan PP, Adjei PE, Zhang Y, Huo Z, Yip BHK, Ip P, Wong ICK, Zhang W, Tham CC, Chen LJ, Zhang XJ, Pang CP, Yam JC. Agyekum S, et al. JAMA Netw Open. 2023 Nov 1;6(11):e2340986. doi: 10.1001/jamanetworkopen.2023.40986. JAMA Netw Open. 2023. PMID: 37917061 Free PMC article.
DESIGN, SETTING, AND PARTICIPANTS: In this cost-effectiveness analysis, a Markov model was designed to compare the cost-effectiveness of interventions for controlling myopia progression over 5 years from a societal perspective in a simulated hyp …
DESIGN, SETTING, AND PARTICIPANTS: In this cost-effectiveness analysis, a Markov model was designed to compare the c
Cost-effectiveness analysis of five anti-obesity medications from a US payer's perspective.
Gómez Lumbreras A, Tan MS, Villa-Zapata L, Ilham S, Earl JC, Malone DC. Gómez Lumbreras A, et al. Nutr Metab Cardiovasc Dis. 2023 Jun;33(6):1268-1276. doi: 10.1016/j.numecd.2023.03.012. Epub 2023 Mar 25. Nutr Metab Cardiovasc Dis. 2023. PMID: 37088648
BACKGROUND AND AIMS: To determine the cost-effectiveness of anti-obesity medications (AOM): tirzepatide, semaglutide, liraglutide, phentermine plus topiramate (PpT), and naltrexone plus bupropion (NpB). ...We applied a 3% per-year discount rate and calculated the in …
BACKGROUND AND AIMS: To determine the cost-effectiveness of anti-obesity medications (AOM): tirzepatide, semaglutide, liraglut …
Cost-Effectiveness Analyses in AML: What Have We Learned, How Should This Impact Patient Care, and What Needs to Be Done in the Future?
Bewersdorf JP, Huntington SF, Zeidan AM. Bewersdorf JP, et al. J Natl Compr Canc Netw. 2023 Apr 10;21(5):522-528. doi: 10.6004/jnccn.2023.70012. J Natl Compr Canc Netw. 2023. PMID: 37037494 Review.
Although drug approvals in the United States are not based on budgetary considerations, cost-effectiveness analyses can inform health policy decisions, resource allocation, and societal debates. ...Furthermore, the perspective and the healthcare system from which a …
Although drug approvals in the United States are not based on budgetary considerations, cost-effectiveness analyses can inform …
Cost-effectiveness analysis of radiosurgical capsulotomy versus treatment as usual for treatment-resistant obsessive-compulsive disorder.
Najera RA, Gregory ST, Shofty B, Anand A, Gadot R, Youngerman BE, Storch EA, Goodman WK, Sheth SA. Najera RA, et al. J Neurosurg. 2022 Jul 29;138(2):347-357. doi: 10.3171/2022.5.JNS22474. Print 2023 Feb 1. J Neurosurg. 2022. PMID: 35907186 Review.
Unlike other procedures such as deep brain stimulation and radiofrequency ablation, the cost-effectiveness of SRS-C for TROCD has not been investigated. The authors herein report the first cost-effectiveness analysis of SRS-C for TROCD. METHODS: …
Unlike other procedures such as deep brain stimulation and radiofrequency ablation, the cost-effectiveness of SRS-C for TROCD …
Cost-Effectiveness Analyses of Digital Health Technology for Improving the Uptake of Vaccination Programs: Systematic Review.
Wang Y, Fekadu G, You JH. Wang Y, et al. J Med Internet Res. 2023 May 15;25:e45493. doi: 10.2196/45493. J Med Internet Res. 2023. PMID: 37184916 Free PMC article. Review.
OBJECTIVE: This study aimed to perform a systematic review of the cost-effectiveness analyses of DHIs for the improvement of the uptake of vaccination programs. ...CONCLUSIONS: This study is the first systematic review on cost-effectiveness analyses of …
OBJECTIVE: This study aimed to perform a systematic review of the cost-effectiveness analyses of DHIs for the improvement of t …
A Primer on Cost-Effectiveness Analysis.
Albright RH, Fleischer AE. Albright RH, et al. Clin Podiatr Med Surg. 2024 Apr;41(2):313-321. doi: 10.1016/j.cpm.2023.07.006. Epub 2023 Aug 20. Clin Podiatr Med Surg. 2024. PMID: 38388127 Review.
A cost-effectiveness analysis (CEA) is a type of health economics model that uses a systematic approach to simplify the complexities that exist in health-care decision-making. ...This article reviews major concepts of CEA including results interpretation, key …
A cost-effectiveness analysis (CEA) is a type of health economics model that uses a systematic approach to simplify the …
Cost-effectiveness analysis of empagliflozin in patients with heart failure with reduced ejection fraction in Japan based on the EMPEROR-Reduced trial.
Tsutsui H, Sakamaki H, Momomura SI, Sakata Y, Kotobuki Y, Linden S, Reifsnider OS, Rakonczai P, Stargardter M, Murata T, Hirase T, Nitta D. Tsutsui H, et al. J Cardiol. 2023 Jun;81(6):522-530. doi: 10.1016/j.jjcc.2023.02.007. Epub 2023 Feb 28. J Cardiol. 2023. PMID: 36858174 Free article.
BACKGROUND: Several studies have reported the cost-effectiveness of sodium-glucose co-transporter 2 inhibitors in heart failure patients; however, their economic implications have not been sufficiently elucidated in Japan. METHODS: A Markov cohort model was develope …
BACKGROUND: Several studies have reported the cost-effectiveness of sodium-glucose co-transporter 2 inhibitors in heart failur …
110,041 results
You have reached the last available page of results. Please see the User Guide for more information.